CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD) (Internal Region) Peptide

Details for Product No. ABIN1381971, Supplier: Log in to see
Protein Name
  • cradd
  • MGC89035
  • zgc:101717
  • CRADD
  • DKFZp468A2219
  • LOC100226369
  • raidd
  • MGC78788
  • MRT34
  • RAIDD
  • CASP2 and RIPK1 domain containing adaptor with death domain
  • CASP2 and RIPK1 domain containing adaptor with death, gene 2
  • CRADD
  • cradd
  • LOC100226369
  • LOC100354517
  • cradd.2
  • Cradd
Protein Region
Internal Region
Origin
Human
4
2
2
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Blocked Antibody anti-CRADD antibody (CASP2 and RIPK1 Domain Containing Adaptor with Death Domain) (Middle Region) (ABIN1031051)
Characteristics 19 amino acids near the center of human RAIDD.
Human
Research Area Cancer, Apoptosis/Necrosis
Application Notes RAIDD peptide is used for blocking the activity of RAIDD.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Duan, Dixit: "RAIDD is a new 'death' adaptor molecule." in: Nature, Vol. 385, Issue 6611, pp. 86-9, 1997 (PubMed).

He, Chen, Farzan, Choe, Ohagen, Gartner, Busciglio, Yang, Hofmann, Newman, Mackay, Sodroski, Gabuzda: "CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia." in: Nature, Vol. 385, Issue 6617, pp. 645-9, 1997 (PubMed).

Choe, Farzan, Sun, Sullivan, Rollins, Ponath, Wu, Mackay, LaRosa, Newman, Gerard, Gerard, Sodroski: "The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates." in: Cell, Vol. 85, Issue 7, pp. 1135-48, 1996 (PubMed).